Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs FDC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA FDC SAMRAT PHARMA/
FDC
 
P/E (TTM) x 4,675.3 23.8 19,637.5% View Chart
P/BV x 1.6 3.5 46.9% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 SAMRAT PHARMA   FDC
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-23
FDC
Mar-23
SAMRAT PHARMA/
FDC
5-Yr Chart
Click to enlarge
High Rs1,250318 393.4%   
Low Rs332229 144.9%   
Sales per share (Unadj.) Rs1,005.3107.5 935.1%  
Earnings per share (Unadj.) Rs53.811.7 460.7%  
Cash flow per share (Unadj.) Rs55.914.0 398.5%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs204.3119.5 171.1%  
Shares outstanding (eoy) m3.09165.91 1.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.82.5 30.9%   
Avg P/E ratio x14.723.4 62.8%  
P/CF ratio (eoy) x14.119.5 72.6%  
Price / Book Value ratio x3.92.3 169.1%  
Dividend payout %1.90-   
Avg Mkt Cap Rs m2,44445,368 5.4%   
No. of employees `000NANA-   
Total wages/salary Rs m113,909 0.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,10617,838 17.4%  
Other income Rs m5512 0.9%   
Total revenues Rs m3,11118,350 17.0%   
Gross profit Rs m2392,496 9.6%  
Depreciation Rs m6389 1.7%   
Interest Rs m1241 30.1%   
Profit before tax Rs m2252,578 8.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m59640 9.2%   
Profit after tax Rs m1661,938 8.6%  
Gross profit margin %7.714.0 55.0%  
Effective tax rate %26.224.8 105.5%   
Net profit margin %5.410.9 49.3%  
BALANCE SHEET DATA
Current assets Rs m98614,431 6.8%   
Current liabilities Rs m5287,296 7.2%   
Net working cap to sales %14.840.0 36.9%  
Current ratio x1.92.0 94.5%  
Inventory Days Days8265 3.0%  
Debtors Days Days602251 239.9%  
Net fixed assets Rs m17517,347 1.0%   
Share capital Rs m31166 18.6%   
"Free" reserves Rs m60119,655 3.1%   
Net worth Rs m63119,820 3.2%   
Long term debt Rs m06 0.0%   
Total assets Rs m1,16231,796 3.7%  
Interest coverage x19.364.1 30.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x2.70.6 476.7%   
Return on assets %15.46.2 247.1%  
Return on equity %26.39.8 269.3%  
Return on capital %37.613.2 284.9%  
Exports to sales %4.10-   
Imports to sales %83.38.5 984.0%   
Exports (fob) Rs m127NA-   
Imports (cif) Rs m2,5871,509 171.4%   
Fx inflow Rs m1273,259 3.9%   
Fx outflow Rs m2,5871,509 171.4%   
Net fx Rs m-2,4601,749 -140.6%   
CASH FLOW
From Operations Rs m-941,549 -6.1%  
From Investments Rs m-30111 -27.0%  
From Financial Activity Rs m96-1,800 -5.3%  
Net Cashflow Rs m-28-138 20.5%  

Share Holding

Indian Promoters % 48.6 69.7 69.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.2 10.2 31.8%  
FIIs % 0.0 2.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.4 30.3 169.3%  
Shareholders   8,065 55,341 14.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SAMRAT PHARMA vs FDC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SAMRAT PHARMA vs FDC Share Price Performance

Period SAMRAT PHARMA FDC S&P BSE HEALTHCARE
1-Day -2.03% 0.75% 1.18%
1-Month -10.27% -4.79% -0.75%
1-Year -2.60% 69.30% 61.82%
3-Year CAGR 34.34% 14.66% 18.16%
5-Year CAGR 38.05% 20.64% 19.79%

* Compound Annual Growth Rate

Here are more details on the SAMRAT PHARMA share price and the FDC share price.

Moving on to shareholding structures...

The promoters of SAMRAT PHARMA hold a 48.6% stake in the company. In case of FDC the stake stands at 69.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SAMRAT PHARMA and the shareholding pattern of FDC.

Finally, a word on dividends...

In the most recent financial year, SAMRAT PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 1.9%.

FDC paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of SAMRAT PHARMA, and the dividend history of FDC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.